Savient Pharmaceuticals Company Profile (NASDAQ:SVNT)

About Savient Pharmaceuticals (NASDAQ:SVNT)

Savient Pharmaceuticals logoSavient Pharmaceuticals, Inc. (Savient), incorporated in 1980, is a specialty biopharmaceutical company focused on commercializing KRYSTEXXA (pegloticase) in the United States and completing the development and seeking regulatory approval outside of the United States for KRYSTEXXA, particularly in the European Union. The Company also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. In October 2013, the Company announced that it has elected to file voluntary petitions under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the Court). Effective January 10, 2014, Crealta Pharmaceuticals LLC, a majority owned unit of GTCR LLC acquired Savient Pharmaceuticals Inc.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:SVNT
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $43.10
  • 200 Day Moving Avg: $37.63
  • 52 Week Range: $14.90 - $50.85
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -44.50
  • P/E Growth: 0.00
  • Average Volume: 104,033 shs.
Frequently Asked Questions for Savient Pharmaceuticals (NASDAQ:SVNT)

What is Savient Pharmaceuticals' stock symbol?

Savient Pharmaceuticals trades on the NASDAQ under the ticker symbol "SVNT."

Who are some of Savient Pharmaceuticals' key competitors?

How do I buy Savient Pharmaceuticals stock?

Shares of Savient Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Savient Pharmaceuticals' stock price today?

One share of Savient Pharmaceuticals stock can currently be purchased for approximately $40.05.

MarketBeat Community Rating for Savient Pharmaceuticals (NASDAQ SVNT)
Community Ranking:  1.8 out of 5 ()
Outperform Votes:  26 (Vote Outperform)
Underperform Votes:  47 (Vote Underperform)
Total Votes:  73
MarketBeat's community ratings are surveys of what our community members think about Savient Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Savient Pharmaceuticals (NASDAQ:SVNT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Savient Pharmaceuticals (NASDAQ:SVNT)
No equities research coverage for this company has been tracked by


Earnings History for Savient Pharmaceuticals (NASDAQ:SVNT)
Earnings by Quarter for Savient Pharmaceuticals (NASDAQ:SVNT)
Earnings History by Quarter for Savient Pharmaceuticals (NASDAQ SVNT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/14/2013Q2 2013($0.31)($0.35)$5.84 million$6.10 millionViewN/AView Earnings Details
5/15/2013Q1 2013($0.31)($0.34)$5.65 million$4.70 millionViewN/AView Earnings Details
3/19/2013Q4 2012($0.44)($0.39)$6.18 million$4.95 millionViewN/AView Earnings Details
11/8/2012Q312($0.45)($0.56)$5.87 million$4.91 millionViewN/AView Earnings Details
8/8/2012($0.45)($0.23)ViewN/AView Earnings Details
5/9/2012($0.49)($0.49)ViewN/AView Earnings Details
11/3/2011($0.38)($0.39)ViewN/AView Earnings Details
8/4/2011($0.28)($0.43)ViewN/AView Earnings Details
5/5/2011($0.31)($0.19)ViewN/AView Earnings Details
2/25/2011($0.26)$0.01ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Savient Pharmaceuticals (NASDAQ:SVNT)
Current Year EPS Consensus Estimate: $-1.18 EPS
Next Year EPS Consensus Estimate: $-0.90 EPS


Dividend History for Savient Pharmaceuticals (NASDAQ:SVNT)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Savient Pharmaceuticals (NASDAQ:SVNT)
Insider Trades by Quarter for Savient Pharmaceuticals (NASDAQ:SVNT)
Insider Trades by Quarter for Savient Pharmaceuticals (NASDAQ:SVNT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/22/2013Louis FerrariCEOSell1,020$0.57$581.40View SEC Filing  
2/4/2013Louis FerrariCEOSell62,200$1.01$62,822.00View SEC Filing  
2/4/2013Philip K YachmetzSVPSell30,500$1.01$30,805.00View SEC Filing  
2/4/2013Richard CrowleyEVPSell48,900$1.03$50,367.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Savient Pharmaceuticals (NASDAQ:SVNT)
Latest Headlines for Savient Pharmaceuticals (NASDAQ:SVNT)



Savient Pharmaceuticals (SVNT) Chart for Sunday, July, 23, 2017

This page was last updated on 7/23/2017 by Staff